SCHEMBL20735882

SCHEMBL20735882

c1ccc2c(c1)-c1ccccc1C21c2cc3ccccc3cc2-c2cc3ccc(-c4ccc(-c5ccc6ccc7cccnc7c6n5)cc4)cc3cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.37
CCR5 P51681 2/20 0.37
CCR8 P51685 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MMP2 P08253 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
MMP9 P14780 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MMP8 P22894 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735886 0.95 SMN1; SMN2 (0.39) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL20736839 0.93 SIRT2 (0.37) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL24647377 0.92 KDM4E (0.42) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL20736846 0.91 SMN1; SMN2 (0.37) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL21868728 0.90 KDM4E (0.41) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL20736071 0.90 PDK2 (0.33) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL27250535 0.90 KDM4E (0.31) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL20735943 0.88 PDK2 (0.34) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL21868360 0.88 CCR1 (0.41) CCR1CCR5CCR8SMN1; SMN2KDM4E
SCHEMBL11962213 0.86 CCR1 (0.44) CCR1CCR5CCR8SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CCR1 1730/4885CCR5 3344/4885CCR8 3031/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 CCR1 1730/4885CCR5 3344/4885CCR8 3031/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CCR1 1730/4885CCR5 3344/4885CCR8 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.